BIOCON: CO SELLS 8M EQUITY SHARES OF SYNGENE INTERNATIONAL THROUGH BLOCK DEAL || SHAREHOLDING IN SYNGENE NOW AT 52.46%; CO RECEIVES APPROXIMATELY 6.86B RUPEES FROM SALE

 10 Dec 2024 05:03 PM

BIOCON: CO SELLS 8M EQUITY SHARES OF SYNGENE INTERNATIONAL THROUGH BLOCK DEAL || SHAREHOLDING IN SYNGENE NOW AT 52.46%; CO RECEIVES APPROXIMATELY 6.86B RUPEES FROM SALE

Pharma stocks catch a cold as US softens stance on Biosecure Act

 10 Dec 2024 05:39 AM

Shares of Syngene International dropped 5.7%, Piramal Pharma fell 4.2%, Lauras Labs and Neuland Laboratories declined 3% and Divi's Laboratories fell 2.8% on Monday. The BSE 500 was down 0.1%.

SYNGENE: BLOCK DEAL ALERT - BIOCON TO SELL UPTO 2% STAKE IN CO VIA BLOCK DEALS || TOTAL DEAL SIZE AT $80 MN OR RS 640 CRORES || KOTAK SEC BANKER TO BLOCK DEAL || BLOCK DEAL FLOOR PRICE AT RS 825, UPTO 5% DISCOUNT LIKELY || DEAL SIZE OF 80 LAKH SHARES AS PER TERMS - CNBC AWAAZ, CITING SOURCES

 09 Dec 2024 06:52 PM

SYNGENE: BLOCK DEAL ALERT - BIOCON TO SELL UPTO 2% STAKE IN CO VIA BLOCK DEALS || TOTAL DEAL SIZE AT $80 MN OR RS 640 CRORES || KOTAK SEC BANKER TO BLOCK DEAL || BLOCK DEAL FLOOR PRICE AT RS 825, UPTO 5% DISCOUNT LIKELY || DEAL SIZE OF 80 LAKH SHARES AS PER TERMS - CNBC AWAAZ, CITING SOURCES

SYNGENE: SETBACK FOR INDIAN CDMO SPACE || FATE OF THE US BIOSECURE ACT WITH EACH PASSING DAY THE PROBABILITY OF BIOSECURE ACT PASSING BY THE US SENATE IS REDUCING - SALES NOTE

 04 Dec 2024 09:50 AM

SYNGENE: SETBACK FOR INDIAN CDMO SPACE || FATE OF THE US BIOSECURE ACT WITH EACH PASSING DAY THE PROBABILITY OF BIOSECURE ACT PASSING BY THE US SENATE IS REDUCING - SALES NOTE

SYNGENE: SETBACK FOR INDIAN CDMO SPACE || FATE OF THE US BIOSECURE ACT WITH EACH PASSING DAY THE PROBABILITY OF BIOSECURE ACT PASSING BY THE US SENATE IS REDUCING

 04 Dec 2024 09:47 AM

SYNGENE: SETBACK FOR INDIAN CDMO SPACE || FATE OF THE US BIOSECURE ACT WITH EACH PASSING DAY THE PROBABILITY OF BIOSECURE ACT PASSING BY THE US SENATE IS REDUCING

Tech picks: Mastek, Piramal Pharma among 4 stocks that can rally up to 13% in short term

 02 Dec 2024 09:35 AM

Driven by robust investor sentiment and a political boost, analysts highlight stocks with potential short-term gains. Recommendations include Mastek with a 13% potential upside, Torrent Pharma with 5%, Piramal Pharma with 9%, and Syngene International with 6%, supported by technical breakouts and positive momentum indicators.

Market Trading Guide: Divi’s Lab, Torrent Pharma are 7 stock recommendations for Monday

 01 Dec 2024 01:06 PM

Indian markets ended in green, supported by pharma and auto stocks. Experts recommend stocks like Aeroflex, Syngene, Torrent Pharma, Piramal Pharma, Garware Fibres, GSFC, and Divi’s Laboratories for potential gains.

Stocks to Buy Today: BEL, IndiGo Among Top 9 Trading Ideas for 28 November 2024

 28 Nov 2024 09:11 AM

The Indian market is expected to trade higher on 28 November 2024, supported by positive global cues. Nifty futures closed at 24,309, with options data suggesting a range between 23,800 and 24,800. Experts recommended stocks like BEL, CAMS, Deepak Fertilizers, HAL, InterGlobe Aviation, Syngene, and Bank of India for short-term traders.

Stocks to Buy Today: Wipro, Syngene among top 6 trading ideas for 27 November 2024

 27 Nov 2024 09:06 AM

Indian markets are expected to trade higher on Wednesday, following positive global cues. Nifty futures closed 0.28% lower on Tuesday, with key support levels at 24,150 and 24,000. Experts recommend short-term buys in stocks like Wipro, City Union Bank, Kaynes, Metropolis Healthcare, Syngene, and BirlaSoft, with specified target prices and stop losses.

Apollo Hospitals, Coforge among 5 stocks with long unwinding

 18 Nov 2024 11:43 AM

Five stocks, including Coforge and Syngene, saw long unwinding on November 18, with declines in both open interest and stock prices.